SFDA warned from all skin-whitening injections  products that contain ‘ Glutathione’ due to their risks, non-safety and non-security of the  content of  their additive substances,  stressing that such products are not registered within SFDA and are illegally marketed.

SFDA warned from product under the name  of Paiyouji (Paiyouji natural slimming capsule) which is marketed by Perfumery shops and social networking websites as a natural product for weight loss and slimming, while it is fake and contains restricted pharmaceutical substances and carries misleading allegations.

​SFDA warned from (Xian Ling) cosmetic, which is marketed by normal shops or sold on social networking as a natural product for relieving the pain and rheumatism, while it carries misleading claims, and defraudation with two substances, which are causing negative effects and side symptoms.

SFDA Warned consumers from using ‘Zino Coffee’ product which is manipulated with pharmaceutical material and having false medical claims.

SFDA stated that the product is marketed by Itarat Stores and Websites as a natural and efficient product for curing several diseases. Analysis of the product by SFDA laboratories revealed that such claim is false and incorrect and faked with pharmaceutical materials.

​SFDA would like to warn all consumers about the medical claims of (Bama Herb Drench), a herbal product from Nancy city Aofula pharmaceutical co. ltd, which dissolves in water and its soak is used for massaging legs. The product is promoted in some satellite channels and social networks and websites, as a remover of insomnia, joint pain, menstruation pain , exhaustion, headache, constipation and many medical claims . Such claims are found to be misleading and not true.

قامت صحة كندا بتحذير المستهلكين من استخدام أقراص إنكور للرجال Encore Tabs for Men وذلك بسبب احتوائها على كميات غير مصرح بها من مركبات صيدلانية مماثلة لما يتم استخدامه في الأدوية المصرح باستخدامها وهي مادة تادالافيل tadalafil حيث يستخدم هذا الدواء بوصفة طبية لعلاج أمراض العجز الجنسي لدى الرجال والذي يجب استخدمه تحت إشراف طبي.

FDA notified healthcare professionals and cystic fibrosis patients in U.S that the Agency is investigating the possible connection between the use of a liquid solution of Colistimethate that was premixed for inhalation with a nebulizer and the death of a patient with cystic fibrosis (CF).

FDA notified healthcare professionals and consumers of important information from two recent studies that should be considered when making treatment decisions in pregnant women who take antidepressants. The studies included pregnant women who were treated with selective serotonin reuptake inhibitors (SSRIs), or in a few cases, other antidepressant medications.